<DOC>
	<DOCNO>NCT01022229</DOCNO>
	<brief_summary>The purpose study investigate use natural health product , compare placebo ( inactive substance ) , manage symptom ADHD . The natural health product contain nutrient zinc , magnesium , vitamin B6 vitamin C. Each nutrient evidence suggest child ADHD might lack . As , child ADHD might benefit supplement diet nutrient , especially ADHD child average level . This study measure whether severity ADHD symptom great child low level zinc , magnesium , vitamin B6 , whether severity ADHD symptom decrease supplementation nutrient . This study also monitor adverse reaction side effect take nutrient child . Although natural health product commercially available , use supplement placebo study approve use study Natural Health Products Directorate Health Canada .</brief_summary>
	<brief_title>The Safety Efficacy Compound Natural Health Product Children With Attention Deficit Hyperactivity Disorder ( ADHD )</brief_title>
	<detailed_description>The study randomize control , double blind trial . A population 30 child diagnose ADHD ( n=30 ) randomly assign NHP group ( n=15 ) placebo group ( n=15 ) . The NHP group provide weight-based dose chewable natural health product contain zinc , magnesium , vitamin B6 vitamin C 10 week , additional follow-up post intervention 20 week . The placebo group administer chewable placebo tablet follow regimen . Severity ADHD symptom measure baseline , week 5 week 10 use Connor-3 Parent SNAP-IV validate questionnaire . Nutritional status monitor baseline week 10 change serum zinc erythrocyte magnesium . Children monitor adverse reaction may occur use investigational product.Following informed consent process , participant undergo structure psychiatric interview prior enrollment 4 30 minute study visit 2 10 minute telephone call throughout study . Blood sample take 2 time use topical anesthetic decrease sensation blood draw . Once enrol , child withdraw study time assent participate withdrawn .</detailed_description>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<criteria>Male female child age 612 diagnose ADHD subtype accord DSMIV criterion . A structured diagnostic interview ( Kiddie Sads Present Lifetime Version ) conduct confirm diagnosis ADHD ass comorbid mental health disorder Primary caregiver ( parent guardian ) give informed consent ; child participant give ongoing assent throughout study . Changes participant ' ADHD medication within 6 week study onset . Diagnosis additional mental health disorder use Kiddie Sads . Diagnosis cancer . Antibiotic use period great 2 week within 10 week prior study Diagnosis Type 1 diabetes insulin use Low serum ferritin/iron deficiency ( &lt; 30 ng/ml )</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Attention Deficit Disorder</keyword>
	<keyword>Pediatrics</keyword>
	<keyword>Attention</keyword>
	<keyword>Impulsivity</keyword>
	<keyword>Complementary Therapies</keyword>
</DOC>